Literature DB >> 19901216

Risk of cataract extraction among adult retinoblastoma survivors.

Gabriel Chodick1, Ruth A Kleinerman, Marilyn Stovall, David H Abramson, Johanna M Seddon, Susan A Smith, Margaret A Tucker.   

Abstract

OBJECTIVE: To investigate the risk of cataract extraction among adult retinoblastoma survivors.
DESIGN: A retrospective cohort study was performed on retinoblastoma survivors who received the diagnosis from 1914 to 1984 and were interviewed in 2000. Lens doses were estimated from radiotherapy records. The cumulative time interval to cataract extraction between dose groups was compared using the log-rank test and Cox regression.
RESULTS: Seven hundred fifty-three subjects (828 eyes) were available for analysis for an average of 32 years of follow-up. During this period, 51 cataract extractions were reported. One extraction was reported in an eye with no radiotherapy compared with 36 extractions in 306 eyes with 1 course of radiotherapy and 14 among 38 eyes with 2 or 3 treatments. The average time interval to cataract extraction in irradiated eyes was 51 years (95% confidence interval [CI], 48-54) following 1 treatment and 32 years (95% CI, 27-37) after 2 or 3 treatments. Eyes exposed to a therapeutic radiation dose of 5 Gy or more had a 6-fold increased risk (95% CI, 1.3-27.2) of cataract extraction compared with eyes exposed to 2.5 Gy or less.
CONCLUSIONS: The results emphasize the importance of ophthalmologic examination of retinoblastoma survivors who have undergone radiotherapy. The risk of cataract extraction in untreated eyes with retinoblastoma is comparable with the risk of the general population.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19901216      PMCID: PMC2818500          DOI: 10.1001/archophthalmol.2009.271

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  26 in total

1.  Validity of a personal and family history of cataract and cataract surgery in genetic studies.

Authors:  Heidi Bowie; Nathan G Congdon; Hong Lai; Sheila K West
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-07       Impact factor: 4.799

2.  Retinblastoma: a modification in radiation therapy technique.

Authors:  D R Weiss; J R Cassady; R Petersen
Journal:  Radiology       Date:  1975-03       Impact factor: 11.105

3.  Visual results and ocular complications following radiotherapy for retinoblastoma.

Authors:  P R Egbert; S S Donaldson; K Moazed; A R Rosenthal
Journal:  Arch Ophthalmol       Date:  1978-10

4.  Incidence of cataract and outcomes after cataract surgery in the first 5 years after iodine 125 brachytherapy in the Collaborative Ocular Melanoma Study: COMS Report No. 27.

Authors: 
Journal:  Ophthalmology       Date:  2007-03-06       Impact factor: 12.079

5.  Management of retinoblastoma with radiation.

Authors:  P Lal; B M Biswal; B K Mohanti; G K Rath; S Ghose; T Vasantha; D N Sharma; L S Arya
Journal:  Indian Pediatr       Date:  2001-01       Impact factor: 1.411

6.  Sarcoma and familial retinoblastoma.

Authors:  Celia S Chen; Graeme Suthers; Jacqueline Carroll; Zbigniew Rudzki; James Muecke
Journal:  Clin Exp Ophthalmol       Date:  2003-10       Impact factor: 4.207

7.  Retinoblastoma: review of 30 years' experience with external beam radiotherapy.

Authors:  Claire Phillips; Maree Sexton; Greg Wheeler; John McKenzie
Journal:  Australas Radiol       Date:  2003-09

8.  Epidemiologic associations with cataract in the 1971-1972 National Health and Nutrition Examination Survey.

Authors:  R Hiller; R D Sperduto; F Ederer
Journal:  Am J Epidemiol       Date:  1983-08       Impact factor: 4.897

9.  Sensitive and efficient detection of RB1 gene mutations enhances care for families with retinoblastoma.

Authors:  Suzanne Richter; Kirk Vandezande; Ning Chen; Katherine Zhang; Joanne Sutherland; Julie Anderson; Liping Han; Rachel Panton; Patricia Branco; Brenda Gallie
Journal:  Am J Hum Genet       Date:  2002-12-18       Impact factor: 11.025

10.  The Framingham Eye Study. II. Association of ophthalmic pathology with single variables previously measured in the Framingham Heart Study.

Authors:  H A Kahn; H M Leibowitz; J P Ganley; M M Kini; T Colton; R S Nickerson; T R Dawber
Journal:  Am J Epidemiol       Date:  1977-07       Impact factor: 4.897

View more
  2 in total

1.  Lens Dose-Response Prediction Modeling and Cataract Incidence in Patients With Retinoblastoma After Lens-Sparing or Whole-Eye Radiation Therapy.

Authors:  Steven M Nguyen; Julian Sison; Marjorie Jones; Jesse L Berry; Jonathan W Kim; A Linn Murphree; Vanessa Salinas; Arthur J Olch; Eric L Chang; Kenneth K Wong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-12-08       Impact factor: 7.038

2.  Systemic neoadjuvant chemotherapy for Group B intraocular retinoblastoma (ARET0331): A report from the Children's Oncology Group.

Authors:  Debra L Friedman; Mark Krailo; Doojduen Villaluna; Dan Gombos; Bryan Langholz; Rima Jubran; Carol Shields; Linn Murphree; Joan O'Brien; Sandra Kessel; Carlos Rodriguez-Galindo; Murali Chintagumpala; Anna T Meadows
Journal:  Pediatr Blood Cancer       Date:  2016-12-26       Impact factor: 3.167

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.